Monday, March 10, 2025
Facebook Linkedin Twitter
HomeTagsIDEAYA

IDEAYA

Biotechnology

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

News Desk -
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced a research collaboration with ATTMOS as...
Healthcare

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated...

PR Newswire -
IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...
Biotechnology

IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK

PR Newswire -
IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us